Georgia MPJE Comprehensive Review – Vocabulary Flashcards

Vocabulary flashcards covering licensure, CE, technician rules, GDNA, controlled substances, dispensing regulations, compounding, institutional practice, REMS, USP standards, DEA forms, recalls, and other Georgia-specific MPJE topics.

Georgia RPh Licensure Requirements

Application, ≥18 years old, good moral character, ACPE-accredited PharmD, 1,500 internship hours, pass NAPLEX & MPJE, pay all fees

Georgia RPh License Renewal Cycle

Biennially on 12/31 of even-numbered years

Late Renewal Grace Period (RPh)

May renew through 1/31 with late fee; revoked after 1/31

Georgia RPh CE Requirement

30 hours every 2-year cycle

Internship Hour Requirement (GA)

1,500 hours

Intern/Extern Definition – Georgia

Student registered with Board; intern is paid, extern is school-assigned experiential student

Intern License Validity (GA)

Up to 5 years unless earlier termination event occurs

Certified Pharmacy Technician (GA)

Registered technician certified by PTCB

GA Technician CE & Renewal

20 CE hours; renew every odd-numbered year

Pharmacist:Technician Ratio (GA)

Maximum 4:1 (two must be certified if supervising four)

GDNA (Georgia Drugs and Narcotics Agency)

Law-enforcement arm that inspects, investigates, seizes, and subpoenas for drug law compliance

GDNA Special Agent Qualifications

Active GA RPh license, 2 years practice, POST training, clean record

Board of Pharmacy Composition (GA)

8 members – 7 pharmacists + 1 consumer

Code of Professional Conduct – Core Duty

Protect public health & maintain trust in pharmacy profession

Refusal to Fill – Acceptable Basis

Professional judgment or deeply held ethical/moral belief

Generic Substitution Requirement (GA)

Must dispense pharmaceutically equivalent (Orange Book) unless prescriber writes “brand necessary”

Purple Book Purpose

Lists interchangeable biological products

Emergency Dispensing (State of Emergency)

Up to 30-day maintenance med, no C-II, notify prescriber within 48 h

Emergency Refill (Unable to Reach Prescriber)

One-time 72-hour supply of non-controlled; notify prescriber within 7 days

Drug Therapy Modification Certification

Board-approved course + 3 CE hours; renew annually 12/31

DTM Protocol Record Retention

Keep 10 years after protocol terminates; protocol expires every 2 years

Mail Delivery – Controlled Substance Rule

Schedule II-V must be signed for on delivery

PIC Immediate Notification Items

Closure, ownership/PIC change, drug loss, disaster, break-in, adverse reaction, etc. within 24 h

Retail Pharmacy Minimum Space

150 sq ft prescription department

Pharmacist Absence Limit (Retail)

≤3 hours/day; ≤1.5 hours per single interval

Night Cabinet Inventory Frequency

At least weekly in hospitals

Hospital Pharmacy Director Internal Inspection

Monthly

Emergency Kit Inspection Interval

Every 90 days by pharmacist

Partial Fill C-II – Stock Shortage

Fill remainder within 72 h

Partial Fill C-II – LTCF/Hospice

May partial fill up to 60 days

C-III–V Expiration & Refill Limit

6 months; ≤5 refills

C-III–V Transfer Rule

One transfer only unless real-time shared database

PDMP Reporting Interval (GA)

Within 24 hours of dispensing

DEA Form 106 Purpose

Report theft or significant loss of controlled substances

Pseudoephedrine Daily/30-Day Limits

3.6 g/day; 9 g/30 days

OTC CV Non-PSE Sale Limit

≤4 oz or 32 dosage units per 48 h (≥18 y, photo ID)

Schedule I Definition

High abuse, no accepted medical use (research only)

Dangerous Drug (GA)

Any Rx-only drug not scheduled

Class I Recall

Reasonable probability of serious adverse health; notify patients

Poison Prevention Packaging Act

Child-resistant closures for Rx & many OTC products

DSCSA Goal

Electronic traceability of prescription drug supply chain

VIPPS Certification

NABP seal indicating legitimate internet pharmacy

DEA Registration Form 224

Initial registration for pharmacies to handle controlled substances

DEA Number Checksum Rule

(1st+3rd+5th) + 2×(2nd+4th+6th) → last digit = 9th digit

DEA Form 222

Order or transfer Schedule I & II drugs

Biennial Controlled Inventory Requirement

Every 2 years; exact count C-II, estimated C-III–V (<1,000 tabs)

Multiple C-II Rx 90-Day Supply Rule

Allowed with ‘Do Not Fill Until’ dates; each Rx dated actual issue date

DATA Waiver Eliminated

X-number no longer required for buprenorphine addiction RX

USP 795 Scope

Non-sterile compounding standards for human & animal

Master Formulation Record

Pre-established recipe and procedure for compounded prep

Compounding Record

Actual preparation log documenting lot, ingredients, personnel

BUD – Non-Sterile Solid Dosage

Up to 180 days room temperature

BUD – Non-Preserved Aqueous Prep

14 days refrigerated

Category 1 CSP

Made in SCA, ISO 5 PEC; BUD ≤12 h RT or 24 h fridge

Category 2 CSP

Made in cleanroom suite; BUD >24 h; more controls

Category 3 CSP

Sterility tested; BUD up to 180 days

ISO Class 5

≤3,520 particles ≥0.5 µm/m³; critical work zone for sterile compounding

Hazardous Drug Negative Pressure Storage

External ventilation, negative pressure room, ≥12 ACPH

Assessment of Risk (HD)

Document allowing alternatives to full USP 800 containment

5 Percent Rule (Wholesale Exemption)

Pharmacy transfers ≤5% of total annual dosage units without wholesaler license

Remote Order Entry Pharmacist

GA-licensed RPh processing orders offsite; no dispensing or counseling

Automated Pharmacy System Stocking

Only pharmacist or supervised intern/tech may load meds

Remote Automated Medication System (RAMS)

Automated system in SNF/hospice dispensing up to 30-day supply; nurses retrieve doses

Adulterated Drug

Filthy, decomposed, unsanitary, incorrect strength/quality

Misbranded Drug

False/misleading label or missing required information

Orphan Drug

Treats ≤200,000 patients; receives incentives

Narrow Therapeutic Index (NTI) Drug

Small difference between effective and toxic dose

iPledge Program

REMS for isotretinoin to prevent fetal exposure

Clozapine REMS Requirement

ANC monitoring to mitigate agranulocytosis risk

Class A (III) Balance

Traditional torsion balance accurate to 6 mg; required equipment

Laminar Airflow Hood

Primary engineering control (ISO 5) for sterile compounding

USP 800 Training Frequency

Initially and every 12 months

Pharmacy Drive-Thru Lane Limit

Maximum of two; farthest no more than 24 ft from window

Hospital Schedule II Storage

Locked safe or dedicated controlled-access room

Perpetual Inventory Requirement (Hospital C-II)

Continuous running log of all C-II transactions

Consultant Pharmacist (LTCF) Role

Monthly drug regimen review and irregularity reporting

Vendor Pharmacist (LTCF) Role

Dispensing, labeling, delivery, record-keeping for facility

Standing Orders in Nursing Facilities

Prohibited; must use complete order instead

LTCF Emergency Kit Prescription Window

Physician must provide new order within 72 hours after kit access

Veterinary Office-Use Compounding 5 % Cap

Dispensed amounts for office/emergency use ≤5% of pharmacy’s yearly compounded volume

Veterinary Emergency Dispensing Supply

≤10-day supply (updated 2025) for urgent condition

“Brand Necessary” Requirement

Prescriber’s own handwriting on Rx to block substitution

Security Paper for Hardcopy C-II

Mandatory to deter duplication/alteration

Pharmacist Initials on Controlled Rx

Initials, fill date, serial number on face or rear (back-tag)

Federal Caution Statement

“Caution: Federal law prohibits the transfer of this drug to any person other than the patient…”

DEA Theft/Loss Reporting Deadline (GA)

Notify DEA/GDNA within 3 days; initial Board notice 24 h

Pseudoephedrine Logbook Retention

2 years

Pharmacy Record Retention (General)

≥2 years; compounded records 5 years (GA) or 2 years (USP)

Drug Sample Record Requirement

Practitioners must log receipt and each sample dispensed

Optometrist Oral Analgesic Limit (GA)

72-hour non-controlled; 48-hour hydrocodone

Mid-Level C-II Emergency Authority (2025)

PA/APRN may prescribe oxycodone/hydrocodone only in emergencies with protocol, 1-year experience, extra CE

Institutional C-II Floor Stock Dispensing Limit

7-day supply

Institutional C-III–V Floor Stock Limit

34-day supply or 100 dosage units

Phase 1 Clinical Trial Goal

Evaluate safety, PK, toxicity in 20–80 subjects

Phase 3 Clinical Trial Goal

Confirm efficacy & safety in 1,000–3,000 subjects

ANDA Purpose

Abbreviated New Drug Application for generics

SNDA Purpose

Supplemental NDA to change manufacture or new indication

Prescription Drug Marketing Act Sample Rule

Practitioners may receive/dispense samples; must keep detailed records

Pharmacy Remote Processing Patient Notice

Must inform patients their Rx may be processed elsewhere

Central Fill Pharmacy Counseling

Originating pharmacy retains counseling duty